UCL spin-outs win at 2019 SEHTA MedTech Business Awards
11 February 2020
On Thursday 6 February, SEHTA held their 2019 MedTech Business Awards. Two UCL spin-outs took home awards for best businesses.
Odin Vision won the Best Start-Up Award and were runners up in the Best Investment Award. Odin Vision is leading a new era of artificial intelligence in endoscopy. They are developing technology that can help doctors improve the detection of cancer.
Odin Vision has featured on the BBC and Reuters, is a Beauhurst top UK AI start-up and has won grants from Innovate UK, European Space Agency, Royal Society and Royal Academy of Engineering.
“We are very grateful to the awards committee, SEHTA and Endomag for sponsoring the best start-up award. It is a very exciting time in MedTech with artificial intelligence being used to create a new generation of clinical applications that support doctors and improve patient outcomes.” Peter Mountney CEO Odin Vision
Peter Mountney, Odin Vision CEO, and Neil Roberts, SEHTA COO
‘Investment of the Year’ was awarded to Echopoint Medical for their achievements in receiving equity investment from UCL Technology Fund and Parkwalk Advisors as well significant Innovate UK grants to develop their platform.
Dr David Parry, CEO, SEHTA said; “Once again our awards have demonstrated the excellence of small health technology companies in the South East, London and for the first time Cambridge, East Anglia & Essex regions. This year was especially competitive”.
The winners have been entered into the national Medilink UK Awards taking place on 1 April at the Hilton Birmingham Metropole, which is part of the 2020 Med-Tech Innovation Expo.